IVAX, Generic Giant Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX, Generic Giant

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: El Swiggum who wrote (139)	4/2/1997 8:54:00 PM
From: harkenman	of 212

Ivax Gets Tentative FDA Approval For Acyclovir ANDA MIAMI (Dow Jones)--Ivax Corp. (IVX) received Food and Drug Administration tentative approval of its abbreviated new drug application for acyclovir in 200 milligram capsules. As reported on March 3, Ivax received FDA tentative approval of its abbreviated NDA for acyclovir in 400 and 800 milligram tablets. In a perss release Wednesday, Ivax said acyclovir is indicated for the treatment of genital herpes, herpes zoster and chickenpox, and is the generic equivalent of Glaxo Wellcome PLC's (GLX) Zovirax. Generic versions of acyclovir may not be marketed or sold in the U.S. until April 22, 1997, the date the patent for Zovirax expires. Ivax said once final approval is received it will market acyclovir through its Zenith Goldline Pharmaceuticals unit. Ivax is a health care products holding compnay.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next